We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-11.77%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$206M
AUM Growth
+$13.8M
Cap. Flow
+$393M
Cap. Flow %
191%
Top 10 Hldgs %
54.28%
Holding
94
New
23
Increased
21
Reduced
13
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 56.15%
2 Industrials 14.14%
3 Financials 9.65%
4 Technology 4.03%
5 Materials 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LH icon
76
CALL
Labcorp
LH
$23.2B
-58,200
Closed -$90K
MCK icon
77
McKesson
MCK
$98.5B
-51,300
Closed -$11.5M
MRK icon
78
Merck
MRK
$315B
-67,072
Closed -$3.64M
NSC icon
79
PUT
Norfolk Southern
NSC
$76.4B
-100,000
Closed -$320K
PAG icon
80
Penske Automotive Group
PAG
$13.3B
-42,500
Closed -$2.21M
SCI icon
81
Service Corp International
SCI
$10.9B
-220,000
Closed -$6.47M
SPY icon
82
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$774B
-350,000
Closed -$1.62M
URI icon
83
PUT
United Rentals
URI
$65.5B
-50,000
Closed -$119K
UUP icon
84
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$432M
-200,000
Closed -$44K
VALE icon
85
PUT
Vale
VALE
$60.4B
-200,000
Closed -$86K
VYX icon
86
CALL
NCR Voyix
VYX
$1.13B
-81,500
Closed -$46K
WMT icon
87
PUT
Walmart Inc
WMT
$909B
-75,000
Closed -$19K
XOM icon
88
ExxonMobil
XOM
$611B
-2,615
Closed -$218K
VIRX
89
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-1,905
Closed -$208K
VIRX
90
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-1,071
Closed -$677K
EGIO
91
CALL
DELISTED
Edgio, Inc. Common Stock
EGIO
-1,930
Closed -$23K
JASNW
92
CALL
DELISTED
Jason Industries, Inc.
JASNW
-527,590
Closed -$229K
LOCK
93
CALL
DELISTED
LifeLock, Inc.
LOCK
-50,000
Closed -$8K
VPCO
94
DELISTED
VAPOR CORP DEL COM STK
VPCO
-8,309
Closed -$13K

Similar funds

DSC Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, DSC Advisors held 94 positions worth $206M, up 7.2% from $192M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

DSC Advisors deployed $393M of net new capital in Q3 2015, opening 23 new positions and adding to 21 existing holdings. Its largest new stake was Neos Therapeutics, Inc: 907,358 shares worth $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 62% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Alkermes, an estimated $1.48M trimmed.

  • DSC Advisors's largest Q3 2015 buy was Neos Therapeutics, Inc: 907,358 shares worth $17.2M.
  • DSC Advisors added most to Apple in Q3 2015, an estimated $2.87M increase.
  • DSC Advisors's biggest Q3 2015 reduction was Alkermes, cutting an estimated $1.48M.
  • DSC Advisors fully exited McKesson in Q3 2015, selling an estimated $11.5M.
  • DSC Advisors's ten largest holdings make up 54% of its $206M portfolio in Q3 2015.
  • DSC Advisors opened 23 new positions and closed 30 in Q3 2015.
  • DSC Advisors's portfolio value rose 7.2% quarter-over-quarter to $206M.

Based on DSC Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.